Forbes reports -
Based on fund-raising deals agreed over the past 12 months, the most highly- valued British growth companies according to Beauhurst right now are:
Oxford Nanopore Technologies: Worth 930m at its most recent fund-raising
This Oxford spin-out continues to grab headlines. With follow-on investment from IP Group, Invesco IVZ -3.09% Perpetual, and Woodford Patient Capital Trust (run by Britains best known fund manager, Neil Woodford), Oxford Nanopore has completed eight equity fundraisings to date. The company is developing and commercialising a DNA sequencer based on nanopore sensing.
StreetInsider reports -
Illumina, Inc. (NASDAQ: ILMN) today announced that the company filed lawsuits against Oxford Nanopore Technologies Ltd. and Oxford Nanopore Technologies, Inc. (ONT). The lawsuits were filed concurrently with the U.S. International Trade Commission and in the U.S. District Court for the Southern District of California. Illumina is seeking all available remedies.
The lawsuits are based on U.S. Patent Nos. 8,673,550 and 9,170,230, which are entitled MSP NANOPORES AND RELATED METHODS. Illumina has exclusively licensed the patents in the field of nucleic acid sequencing from the UAB Research Foundation and the University of Washington. The lawsuits focus on ONTs MinION and PromethION devices.